Autoimmune polyendocrine syndrome type 1 (APS-1) is an inherited autoimmune condition caused by mutations in the autoimmune regulator (AIRE) gene. Symptoms often begin in childhood and are characterized by mucocutaneous candidiasis, hypoparathyroidism, and Addison’s disease. Complications of this disorder can affect the skin and nails, the gonads, the eyes, the thyroid, and the digestive system. Type 1 diabetes also occurs in some patients with this condition. Symptoms of APS-1 often develop earlier and are more severe than symptoms of APS-2, a related disease.

 

PATHOPHYSIOLOGY & EPIDEMIOLOGY

APS-1 is a progressive disease, with different symptoms typically appearing at different stages. For example, chronic mucocutaneous candidiasis and hypoparathyroidism often appear in childhood while adrenal insufficiency often starts around age 20.

APS-1 is inherited in autosomal recessive fashion due to a defect in the AIRE gene.

The estimated prevalence of APS-1 in most countries is approximately 1:100,000. However, higher rates are reported in Finland at 1:25,000, Sardinia at 1:14,000, and among Persian Jews living in Israel at 1:9,000.

SIGNS & SYMPTOMS

The most common symptoms of APS-1 include:

  • Abnormal calcium-phosphate regulating hormone level
  • Abnormal fingernail morphology
  • Abnormality of the cerebral vasculature
  • Adrenal hyperplasia
  • Autoimmunity
  • Chronic mucocutaneous candidiasis
  • Decreased circulating cortisol level
  • Opacification of the corneal stroma
  • Photophobia
  • Visual impairment
  • Cataract
  • Alopecia
  • Cerebral calcification
  • Hypopigmented skin patches
DIAGNOSIS

Diagnosis for this condition often involves endoscopies, CT scans, serum endocrine autoantibody screens, and histologic tests

MANAGEMENT STRATEGIES & TREATMENT

While the treatment of APS-1 depends upon an individuals’ specific features, general management includes hormone replacement therapy. Additionally, mucocutaneous candidiasis is treated with oral antifungal agents, such as fluconazole or itraconazole. Hypoparathyroidism is treated with a combination of oral calcium and vitamin D (usually, calcitriol). Adrenal insufficiency is treated with oral corticosteroids and mineralosteroids. Adrenal gland transplants may also be indicated.

Patients with APS-1 require a multidisciplinary approach to treatment led by an endocrinologist.

To learn more about autoimmune polyendocrine syndrome and other autoimmune disorders visit, https://checkrare.com/diseases/autoimmune-auto-inflammatory-disorders/